GLP-1 therapies, lifestyle spending accounts, expanded family-forming programs, and caregiving benefits are reshaping the cost structure and competitive dynamics of employer-sponsored healthcare. What were once emerging offerings are now strategic decisions with meaningful financial, clinical, and workforce implications.
This session examines how HR leaders can evaluate adoption, manage risk, and align innovation with long-term sustainability through both a workforce and fiduciary lens — balancing employee demand, health outcomes, and long-term cost containment.
You'll leave with: a structured framework for assessing emerging benefits, aligning innovation with financial responsibility, and building a business case that demonstrates measurable value.